These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18880597)

  • 1. The haemagglutinin of Haemophilus pertussis; haemagglutinin as a protective antigen in experimental murine pertussis.
    KEOGH EV; NORTH EA
    Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):315-22. PubMed ID: 18880597
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
    van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
    Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some factors influencing the virulence of Haemophilus pertussis Phase I.
    GRAY DF
    Aust J Exp Biol Med Sci; 1946 Dec; 24(4):301-11. PubMed ID: 20257529
    [No Abstract]   [Full Text] [Related]  

  • 4. The behaviour of Haemophilus pertussis in casein hydrolysate broth.
    FISHER S
    Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):299-306. PubMed ID: 18880595
    [No Abstract]   [Full Text] [Related]  

  • 5. On the protective antigen of phase 1 H. pertussis.
    KUWAJIMA Y; MASUI M; SHIMURA N
    Yokohama Med Bull; 1952 Jun; 3(3):131-9. PubMed ID: 13029568
    [No Abstract]   [Full Text] [Related]  

  • 6. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.
    Tuomanen E; Weiss A; Rich R; Zak F; Zak O
    Dev Biol Stand; 1985; 61():197-204. PubMed ID: 2872105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the antigenicity of toxic extracts of Hemophilus pertussis.
    VERWEY WF; THIELE EH
    J Immunol; 1949 Jan; 61(1):27-33. PubMed ID: 18109231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriology of whooping cough. II. Determination of the major agglutinant factors in Bordetella pertussis samples isolated in Rio de Janeiro].
    Ubatuba A; Salmito AT
    Hospital (Rio J); 1970; 78(5):1301-10. PubMed ID: 4327251
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectivity of Hemophilus pertussis for the chick embryo.
    SHAFFER MF; SHAFFER LS
    Proc Soc Exp Biol Med; 1946 Jun; 62(2):244. PubMed ID: 20993182
    [No Abstract]   [Full Text] [Related]  

  • 13. A simplified liquid culture medium for the growth of Hemophilus pertussis.
    VERWEY WF; THIELE EH; SAGE DN
    J Bacteriol; 1947 Jul; 54(1):71. PubMed ID: 20255167
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological correlates in whooping cough.
    Granström M; Granström G
    Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
    Alonso JM; Rocancourt M; Le Nin S; Brezin C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
    Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
    Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.